Jiayu Wang

2.2k total citations
112 papers, 1.4k citations indexed

About

Jiayu Wang is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiayu Wang has authored 112 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 52 papers in Cancer Research and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiayu Wang's work include Breast Cancer Treatment Studies (35 papers), Cancer Treatment and Pharmacology (33 papers) and HER2/EGFR in Cancer Research (22 papers). Jiayu Wang is often cited by papers focused on Breast Cancer Treatment Studies (35 papers), Cancer Treatment and Pharmacology (33 papers) and HER2/EGFR in Cancer Research (22 papers). Jiayu Wang collaborates with scholars based in China, United States and United Kingdom. Jiayu Wang's co-authors include Fei Ma, Pin Zhang, Ying Fan, Binghe Xu, Ruigang Cai, Yang Luo, Qiao Li, Peng Yuan, Shanshan Chen and Binghe Xu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and NeuroImage.

In The Last Decade

Jiayu Wang

101 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiayu Wang China 21 709 512 479 368 121 112 1.4k
Yiding Chen China 21 710 1.0× 526 1.0× 975 2.0× 247 0.7× 147 1.2× 86 2.0k
Lijun Di China 25 602 0.8× 389 0.8× 1.0k 2.2× 188 0.5× 90 0.7× 102 1.9k
Evgeny V. Denisov Russia 22 700 1.0× 494 1.0× 679 1.4× 214 0.6× 70 0.6× 92 1.6k
Shou‐Ching Tang United States 24 542 0.8× 504 1.0× 1.3k 2.6× 230 0.6× 72 0.6× 85 1.8k
Beihua Kong China 29 523 0.7× 525 1.0× 990 2.1× 334 0.9× 164 1.4× 99 2.3k
Daqing Wu United States 24 460 0.6× 279 0.5× 942 2.0× 329 0.9× 87 0.7× 56 1.7k
Ana Bosch Sweden 16 832 1.2× 545 1.1× 661 1.4× 390 1.1× 117 1.0× 43 1.6k
Ayodele Alaiya Saudi Arabia 32 735 1.0× 345 0.7× 1.6k 3.2× 313 0.9× 122 1.0× 80 2.7k
Kyong‐Ah Yoon South Korea 23 526 0.7× 593 1.2× 910 1.9× 368 1.0× 185 1.5× 76 1.6k
Fuming Qiu China 26 730 1.0× 498 1.0× 863 1.8× 200 0.5× 87 0.7× 55 2.1k

Countries citing papers authored by Jiayu Wang

Since Specialization
Citations

This map shows the geographic impact of Jiayu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayu Wang more than expected).

Fields of papers citing papers by Jiayu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayu Wang. The network helps show where Jiayu Wang may publish in the future.

Co-authorship network of co-authors of Jiayu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayu Wang. A scholar is included among the top collaborators of Jiayu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayu Wang. Jiayu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jiayu, Pengzhan He, Cheng Liu, et al.. (2025). Discovery of Natural Compound α‐Hederin via Large‐Scale Screening as a Targeted JAK/STAT3 Inhibitor for Ovarian Cancer Therapy. Advanced Science. 12(38). e17278–e17278.
2.
Xu, Shili, Zihua Xuan, Jiayu Wang, et al.. (2025). Er Miao San Attenuates Collagen-Induced Arthritis Mice by Regulating Gut Microbiota and Its Metabolites. Journal of Microbiology and Biotechnology. 35. e2507054–e2507054.
3.
Lan, Bo, Jiayu Wang, Qiao Li, et al.. (2025). The ideal strategies of antibody‒drug conjugate sequential treatment in HER2-expressing metastatic breast cancer: A multi-center real-world study. The Breast. 81. 104470–104470. 3 indexed citations
4.
5.
Liu, Yuqian, Jun Gao, Zhijuan Nie, et al.. (2023). Integration of metagenome and metabolome analysis reveals the correlation of gut microbiota, oxidative stress, and inflammation in Coilia nasus under air exposure stress and salinity mitigation. Comparative Biochemistry and Physiology Part D Genomics and Proteomics. 49. 101175–101175. 5 indexed citations
6.
7.
Wang, Jiayu, et al.. (2023). MiR-29b detection in serum using an electrochemical biosensor for the early diagnosis of gestational diabetes. Analytical Biochemistry. 674. 115209–115209. 3 indexed citations
8.
Chen, Hongwei, et al.. (2023). OsABC1K3, encodes an ABC1-like kinase, involved PGR5-dependent cyclic electron transport in rice. Environmental and Experimental Botany. 209. 105309–105309. 1 indexed citations
9.
Gao, Yanpan, Jiaqi Liu, Jiayu Wang, et al.. (2022). Proteomic analysis of human hippocampal subfields provides new insights into the pathogenesis of Alzheimer’s disease and the role of glial cells. Brain Pathology. 32(4). e13047–e13047. 26 indexed citations
10.
Wang, Jiayu, et al.. (2022). A Multi-Classification Accessment Framework for Reproducible Evaluation of Multimodal Learning in Alzheimer's Disease. IEEE/ACM Transactions on Computational Biology and Bioinformatics. 21(4). 559–572. 10 indexed citations
11.
Wang, Jiayu, Fei Ma, Yang Luo, et al.. (2020). Platinum‐based chemotherapy in advanced triple‐negative breast cancer: A multicenter real‐world study in China. International Journal of Cancer. 147(12). 3490–3499. 9 indexed citations
12.
Wang, Jiayu, Yubo Wang, K. Liu, Xiaojun Bi, & Jie Sun. (2020). Using arterial blood as a substitute for venous blood in routine biochemistry parameter examinations in rabbits. BMC Veterinary Research. 16(1). 467–467. 2 indexed citations
13.
Wang, Jiayu, Wei Chen, Michihiro Nagao, et al.. (2019). Tailoring Biomimetic Phosphorylcholine-Containing Block Copolymers as Membrane-Targeting Cellular Rescue Agents. Biomacromolecules. 20(9). 3385–3391. 12 indexed citations
14.
Lan, Bo, Fei Ma, Xiaoyu Zhai, et al.. (2018). The relationship between the CYP2D6 polymorphisms and tamoxifen efficacy in adjuvant endocrine therapy of breast cancer patients in Chinese Han population. International Journal of Cancer. 143(1). 184–189. 27 indexed citations
15.
Lan, Bo, Fei Ma, Shanshan Chen, et al.. (2018). The Effect of Polymorphism in UGT1A4 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Patients With Breast Cancer in China. Clinical Breast Cancer. 19(2). e370–e375. 5 indexed citations
16.
Lan, Bo, Fei Ma, Shanshan Chen, et al.. (2018). Toremifene, rather than tamoxifen, might be a better option for the adjuvant endocrine therapy in CYP2D6*10T/T genotype breast cancer patients in China. International Journal of Cancer. 143(10). 2499–2504. 16 indexed citations
17.
Du, Feng, Peng Yuan, Jiayu Wang, et al.. (2015). Effect of Hormone Therapy on Long-term Outcomes of Patients with Human Epidermal Growth Factor Receptor 2-and Hormone Receptor-Positive Metastatic Breast Cancer: Real World Experience in China. Asian Pacific Journal of Cancer Prevention. 16(3). 903–907. 2 indexed citations
18.
Fan, Ying, Xiaoyan Ding, Binghe Xu, et al.. (2015). Prognostic Significance of Single Progesterone Receptor Positivity. Medicine. 94(46). e2066–e2066. 21 indexed citations
19.
Li, Qian, Binghe Xu, Pin Zhang, et al.. (2013). [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].. PubMed. 35(3). 207–11. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yiding Chen Breakdown of academic impact, for papers by Lijun Di Breakdown of academic impact, for papers by Evgeny V. Denisov Breakdown of academic impact, for papers by Shou‐Ching Tang Breakdown of academic impact, for papers by Beihua Kong Breakdown of academic impact, for papers by Daqing Wu Breakdown of academic impact, for papers by Ana Bosch Breakdown of academic impact, for papers by Ayodele Alaiya Breakdown of academic impact, for papers by Kyong‐Ah Yoon Breakdown of academic impact, for papers by Fuming Qiu
Rankless by CCL
2026